Romiplostim

ATC B02BX04 · 9 markets · 22 records

Romiplostim 9 markets · 22 records Forms

AU 6 records · 6 strengths

  • 0.25 mginjectionNplate also in ES·TW
  • 0.5 mginjectionNplate also in US·ES
  • 0.625 mginjectionNPLATE romiplostim (rbe) 625 microgram powder for injection vial unknown
  • 0.375 mginjectionNPLATE romiplostim (rbe) 375 microgram powder for injection vial unknown
  • 0.23 mginjectionNPLATE romiplostim (rbe) 230 microgram powder for injection vial unknown

Records without a stated strength · 1 Nplate

US 3 records · 3 strengths

GB 3 records · 1 strengths

    Records without a stated strength · 1 Nplate 125microgram powder for solution for injection vials、Nplate 250microgram powder and solvent for solution for injection vials、Nplate 250microgram powder for solution for injection vials

    ES 3 records · 2 strengths

    CA 2 records · 2 strengths

    SG 1 records · 1 strengths

      Records without a stated strength · 1 ROMIPLATE POWDER FOR SOLUTION FOR INJECTION 250 μg/vial

      TW 1 records · 1 strengths

      HK 1 records · 1 strengths

        Records without a stated strength · 1 ROMIPLATE POWDER FOR SOLUTION FOR INJECTION 250MCG

        EU 1 records · 1 strengths

        EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

          Records without a stated strength · 1 Nplate

          The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

          Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

          A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.